Graves’ disease is a disorder in which the immune system attacks the thyroid, causing the gland to overproduce thyroid hormones. It’s a common cause of hyperthyroidism, or an overactive ...

Merida Biosciences has emerged from Third Rock Ventures with $121 million in first-round financing for a pipeline of drugs for autoimmune diseases, headed by a Graves' disease candidate.